Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Establishing Basic Science-Clinical Collaborations to Understand the Molecular Mechanisms of Heterotaxy

$1.62M USD

Funder EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Recipient Organization University of Virginia
Country United States
Start Date Aug 01, 2024
End Date Jul 31, 2026
Duration 729 days
Number of Grantees 3
Roles Principal Investigator; Co-Investigator
Data Source NIH (US)
Grant ID 10887951
Grant Description

Congenital heart disease (CHD) is the most common birth defect that affects nearly 1 in 100 liveborn infants. Heterotaxy (HTX) is a severe form affecting 3-4% of CHD patients where left- right (LR) asymmetry of internal organs is not established correctly. Epidemiological studies suggest that genetics plays a significant role in CHD. Uncovering the genetic pathogenesis for

CHD is essential to provide a more accurate prognosis for CHD-related interventions, assess the risk for neurodevelopmental delays, and counsel families about recurrence risks. However, infants that undergo clinical genetic testing, known mutations and genes that cause CHD are identified in

All Grantees

University of Virginia

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant